| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medicaid | 49 | 2024 | 2843 | 5.130 |
Why?
|
| Medicare | 66 | 2024 | 6888 | 4.390 |
Why?
|
| Reimbursement Mechanisms | 17 | 2023 | 677 | 4.370 |
Why?
|
| Patient Protection and Affordable Care Act | 23 | 2022 | 1189 | 4.050 |
Why?
|
| Quality of Health Care | 59 | 2023 | 4339 | 3.980 |
Why?
|
| Hospitals | 47 | 2024 | 3904 | 3.870 |
Why?
|
| Insurance Coverage | 23 | 2024 | 1946 | 3.600 |
Why?
|
| Reimbursement, Incentive | 17 | 2017 | 549 | 2.970 |
Why?
|
| Hospital Administration | 9 | 2019 | 353 | 2.400 |
Why?
|
| Skilled Nursing Facilities | 8 | 2023 | 406 | 2.290 |
Why?
|
| Economics, Hospital | 10 | 2021 | 210 | 2.180 |
Why?
|
| Quality Indicators, Health Care | 30 | 2014 | 1812 | 2.140 |
Why?
|
| Insurance, Health | 29 | 2022 | 2518 | 2.090 |
Why?
|
| Medically Uninsured | 17 | 2020 | 841 | 2.070 |
Why?
|
| State Health Plans | 11 | 2017 | 220 | 2.060 |
Why?
|
| Managed Care Programs | 16 | 2008 | 941 | 1.960 |
Why?
|
| United States | 189 | 2024 | 73186 | 1.820 |
Why?
|
| Health Services Accessibility | 40 | 2024 | 5522 | 1.800 |
Why?
|
| Health Expenditures | 14 | 2021 | 2396 | 1.790 |
Why?
|
| Subacute Care | 5 | 2021 | 188 | 1.770 |
Why?
|
| Poverty | 22 | 2024 | 2720 | 1.750 |
Why?
|
| Patient Readmission | 16 | 2021 | 3313 | 1.740 |
Why?
|
| Quality Assurance, Health Care | 21 | 2018 | 2182 | 1.710 |
Why?
|
| State Government | 8 | 2020 | 389 | 1.680 |
Why?
|
| Arthroplasty, Replacement | 3 | 2021 | 311 | 1.630 |
Why?
|
| Employment | 6 | 2022 | 1114 | 1.630 |
Why?
|
| Episode of Care | 5 | 2021 | 128 | 1.580 |
Why?
|
| Diagnosis-Related Groups | 14 | 2021 | 447 | 1.480 |
Why?
|
| Eligibility Determination | 6 | 2019 | 421 | 1.300 |
Why?
|
| Group Practice | 5 | 2021 | 151 | 1.240 |
Why?
|
| Health Benefit Plans, Employee | 12 | 2009 | 332 | 1.240 |
Why?
|
| Coronary Artery Bypass | 14 | 2014 | 2194 | 1.180 |
Why?
|
| Health Care Reform | 10 | 2016 | 1262 | 1.150 |
Why?
|
| Physician Incentive Plans | 6 | 2006 | 165 | 1.110 |
Why?
|
| Quality Improvement | 8 | 2024 | 3860 | 1.110 |
Why?
|
| Health Maintenance Organizations | 15 | 2008 | 657 | 1.060 |
Why?
|
| Attitude to Health | 10 | 2020 | 2025 | 1.050 |
Why?
|
| Health Care Costs | 9 | 2020 | 3270 | 0.990 |
Why?
|
| Governing Board | 4 | 2013 | 50 | 0.990 |
Why?
|
| Healthcare Disparities | 10 | 2018 | 3421 | 0.970 |
Why?
|
| Pneumonia | 13 | 2018 | 2164 | 0.960 |
Why?
|
| Health Services for the Aged | 6 | 2011 | 264 | 0.870 |
Why?
|
| Hospital Mortality | 12 | 2013 | 5369 | 0.820 |
Why?
|
| Public Opinion | 3 | 2017 | 486 | 0.810 |
Why?
|
| Acquired Immunodeficiency Syndrome | 14 | 1997 | 2203 | 0.790 |
Why?
|
| Information Services | 7 | 2000 | 239 | 0.730 |
Why?
|
| Physicians | 17 | 2021 | 4607 | 0.720 |
Why?
|
| Total Quality Management | 6 | 2004 | 265 | 0.710 |
Why?
|
| Hospital Costs | 6 | 2018 | 959 | 0.710 |
Why?
|
| Data Collection | 14 | 2019 | 3324 | 0.700 |
Why?
|
| Insurance Carriers | 2 | 2022 | 159 | 0.680 |
Why?
|
| Humans | 257 | 2024 | 768970 | 0.670 |
Why?
|
| Benchmarking | 9 | 2010 | 1059 | 0.660 |
Why?
|
| Myocardial Infarction | 20 | 2018 | 11521 | 0.660 |
Why?
|
| Arkansas | 5 | 2024 | 59 | 0.660 |
Why?
|
| Insurance, Pharmaceutical Services | 6 | 2011 | 348 | 0.660 |
Why?
|
| Health Status Disparities | 4 | 2020 | 1886 | 0.650 |
Why?
|
| Patient Discharge | 11 | 2023 | 3491 | 0.640 |
Why?
|
| Vulnerable Populations | 5 | 2018 | 718 | 0.620 |
Why?
|
| State Medicine | 4 | 2013 | 219 | 0.610 |
Why?
|
| Patient Satisfaction | 12 | 2014 | 3492 | 0.610 |
Why?
|
| Frail Elderly | 3 | 2024 | 781 | 0.610 |
Why?
|
| Efficiency, Organizational | 3 | 2011 | 699 | 0.540 |
Why?
|
| Fee-for-Service Plans | 7 | 2024 | 714 | 0.540 |
Why?
|
| Aged, 80 and over | 46 | 2024 | 59739 | 0.540 |
Why?
|
| Social Perception | 1 | 2020 | 433 | 0.530 |
Why?
|
| Aged | 95 | 2024 | 171786 | 0.530 |
Why?
|
| Hospitalization | 18 | 2024 | 10847 | 0.520 |
Why?
|
| Health Care Surveys | 15 | 2019 | 2437 | 0.510 |
Why?
|
| Minority Groups | 2 | 2014 | 1216 | 0.510 |
Why?
|
| Health Status | 15 | 2022 | 4095 | 0.500 |
Why?
|
| Politics | 5 | 2017 | 822 | 0.480 |
Why?
|
| Female | 139 | 2024 | 397515 | 0.480 |
Why?
|
| Male | 129 | 2024 | 365203 | 0.480 |
Why?
|
| Private Sector | 4 | 2019 | 396 | 0.470 |
Why?
|
| Administrative Personnel | 2 | 2014 | 185 | 0.450 |
Why?
|
| Heart Failure | 15 | 2021 | 11879 | 0.450 |
Why?
|
| Developed Countries | 3 | 2007 | 452 | 0.430 |
Why?
|
| Cost Savings | 5 | 2017 | 915 | 0.430 |
Why?
|
| Health Services | 5 | 2015 | 755 | 0.420 |
Why?
|
| Budgets | 2 | 2013 | 232 | 0.420 |
Why?
|
| Social Class | 4 | 2008 | 2009 | 0.420 |
Why?
|
| Middle Aged | 85 | 2024 | 223737 | 0.420 |
Why?
|
| Costs and Cost Analysis | 17 | 2020 | 1669 | 0.420 |
Why?
|
| Mortality | 4 | 2021 | 2914 | 0.410 |
Why?
|
| Hospitals, Teaching | 10 | 1998 | 1159 | 0.410 |
Why?
|
| Home Care Services | 3 | 2017 | 660 | 0.410 |
Why?
|
| Ambulatory Care | 15 | 1994 | 2784 | 0.400 |
Why?
|
| Coronary Disease | 10 | 2012 | 5919 | 0.400 |
Why?
|
| Preventive Health Services | 5 | 2017 | 570 | 0.400 |
Why?
|
| Formularies as Topic | 4 | 2005 | 94 | 0.390 |
Why?
|
| Texas | 3 | 2020 | 410 | 0.390 |
Why?
|
| Adult | 88 | 2024 | 223851 | 0.390 |
Why?
|
| Social Environment | 1 | 2016 | 1015 | 0.380 |
Why?
|
| Drug Utilization | 5 | 2012 | 1191 | 0.380 |
Why?
|
| Primary Health Care | 7 | 2016 | 4748 | 0.380 |
Why?
|
| Policy | 1 | 2015 | 514 | 0.370 |
Why?
|
| Medical Errors | 7 | 2011 | 1262 | 0.370 |
Why?
|
| Capitation Fee | 4 | 2004 | 115 | 0.360 |
Why?
|
| Salaries and Fringe Benefits | 4 | 2006 | 262 | 0.360 |
Why?
|
| Surgical Procedures, Operative | 5 | 2005 | 1941 | 0.350 |
Why?
|
| Uncertainty | 2 | 2011 | 769 | 0.350 |
Why?
|
| Patient Admission | 3 | 2011 | 1370 | 0.350 |
Why?
|
| Government Regulation | 2 | 2016 | 525 | 0.340 |
Why?
|
| Logistic Models | 17 | 2018 | 13318 | 0.330 |
Why?
|
| Residence Characteristics | 2 | 2017 | 2121 | 0.330 |
Why?
|
| Risk Adjustment | 5 | 2014 | 603 | 0.330 |
Why?
|
| Thoracic Surgery | 3 | 2013 | 729 | 0.320 |
Why?
|
| Diagnostic Tests, Routine | 7 | 2008 | 790 | 0.320 |
Why?
|
| Program Evaluation | 2 | 2017 | 2508 | 0.320 |
Why?
|
| California | 8 | 2014 | 1443 | 0.320 |
Why?
|
| Length of Stay | 17 | 2023 | 6526 | 0.310 |
Why?
|
| Independent Practice Associations | 3 | 2006 | 21 | 0.310 |
Why?
|
| Drug Prescriptions | 5 | 2005 | 1673 | 0.310 |
Why?
|
| Cost-Benefit Analysis | 11 | 2020 | 5544 | 0.310 |
Why?
|
| Case Management | 2 | 2014 | 277 | 0.310 |
Why?
|
| Drug Costs | 6 | 2012 | 1198 | 0.310 |
Why?
|
| Group Purchasing | 1 | 2007 | 9 | 0.300 |
Why?
|
| Angioplasty, Balloon, Coronary | 5 | 2003 | 1724 | 0.300 |
Why?
|
| Health Policy | 8 | 2022 | 2700 | 0.300 |
Why?
|
| Delivery of Health Care | 8 | 2023 | 5375 | 0.300 |
Why?
|
| Fees and Charges | 6 | 2016 | 191 | 0.290 |
Why?
|
| Kidney Failure, Chronic | 5 | 2008 | 2493 | 0.290 |
Why?
|
| Massachusetts | 28 | 2014 | 8894 | 0.290 |
Why?
|
| Socioeconomic Factors | 20 | 2019 | 7861 | 0.280 |
Why?
|
| Economics, Medical | 1 | 2007 | 112 | 0.280 |
Why?
|
| Referral and Consultation | 8 | 2013 | 3628 | 0.280 |
Why?
|
| Marketing of Health Services | 1 | 2007 | 151 | 0.270 |
Why?
|
| Fees, Medical | 4 | 1992 | 111 | 0.270 |
Why?
|
| Regression Analysis | 11 | 2021 | 6346 | 0.270 |
Why?
|
| Hospital Bed Capacity | 4 | 2008 | 205 | 0.260 |
Why?
|
| Iatrogenic Disease | 1 | 2009 | 552 | 0.260 |
Why?
|
| Attitude of Health Personnel | 12 | 2013 | 3928 | 0.260 |
Why?
|
| Competitive Medical Plans | 1 | 2005 | 26 | 0.260 |
Why?
|
| Kentucky | 2 | 2016 | 83 | 0.250 |
Why?
|
| Technology, High-Cost | 2 | 2004 | 32 | 0.250 |
Why?
|
| Retrospective Studies | 25 | 2024 | 81903 | 0.250 |
Why?
|
| Lovastatin | 2 | 1996 | 115 | 0.250 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2013 | 954 | 0.250 |
Why?
|
| Internal Medicine | 4 | 2009 | 1064 | 0.240 |
Why?
|
| Health Services Needs and Demand | 4 | 2011 | 1407 | 0.240 |
Why?
|
| Interviews as Topic | 13 | 2013 | 2744 | 0.240 |
Why?
|
| Health Services Research | 11 | 2005 | 1818 | 0.240 |
Why?
|
| Hospitalists | 1 | 2009 | 298 | 0.240 |
Why?
|
| Surgery Department, Hospital | 1 | 2006 | 176 | 0.240 |
Why?
|
| Niacin | 2 | 1996 | 117 | 0.240 |
Why?
|
| Income | 7 | 2020 | 1879 | 0.230 |
Why?
|
| Sampling Studies | 4 | 2009 | 615 | 0.230 |
Why?
|
| Guideline Adherence | 4 | 2021 | 2241 | 0.230 |
Why?
|
| Kidney Transplantation | 5 | 2008 | 4265 | 0.230 |
Why?
|
| Medication Adherence | 2 | 2016 | 2192 | 0.230 |
Why?
|
| Public Sector | 1 | 2005 | 266 | 0.230 |
Why?
|
| Young Adult | 14 | 2024 | 60131 | 0.220 |
Why?
|
| Patient Selection | 6 | 2021 | 4265 | 0.220 |
Why?
|
| Safety Management | 2 | 2008 | 765 | 0.210 |
Why?
|
| Specialization | 2 | 2007 | 780 | 0.210 |
Why?
|
| Provider-Sponsored Organizations | 1 | 2002 | 12 | 0.210 |
Why?
|
| Patient Participation | 7 | 2014 | 1448 | 0.210 |
Why?
|
| Diffusion of Innovation | 1 | 2007 | 732 | 0.200 |
Why?
|
| Disclosure | 3 | 2014 | 755 | 0.200 |
Why?
|
| Hypercholesterolemia | 4 | 2000 | 1145 | 0.200 |
Why?
|
| Tamoxifen | 1 | 2007 | 967 | 0.200 |
Why?
|
| Physicians, Family | 1 | 2004 | 349 | 0.200 |
Why?
|
| Cost Control | 8 | 2024 | 627 | 0.200 |
Why?
|
| New York | 4 | 2013 | 884 | 0.190 |
Why?
|
| Patients | 6 | 2013 | 908 | 0.190 |
Why?
|
| Diagnostic Services | 3 | 1987 | 34 | 0.190 |
Why?
|
| Chi-Square Distribution | 6 | 2011 | 3438 | 0.190 |
Why?
|
| Health Facilities, Proprietary | 1 | 2001 | 37 | 0.190 |
Why?
|
| Medicare Part B | 2 | 1993 | 117 | 0.190 |
Why?
|
| Societies, Medical | 2 | 2004 | 3968 | 0.190 |
Why?
|
| Health Facility Administrators | 1 | 2021 | 32 | 0.180 |
Why?
|
| Mass Screening | 4 | 2016 | 5457 | 0.180 |
Why?
|
| Quality of Life | 9 | 2022 | 13510 | 0.180 |
Why?
|
| Depressive Disorder | 2 | 2011 | 3723 | 0.180 |
Why?
|
| Organizations, Nonprofit | 1 | 2001 | 105 | 0.180 |
Why?
|
| United States Public Health Service | 1 | 2020 | 31 | 0.180 |
Why?
|
| Coronary Vessels | 1 | 2012 | 3124 | 0.170 |
Why?
|
| Physician-Patient Relations | 7 | 2008 | 3269 | 0.170 |
Why?
|
| Long-Term Care | 1 | 2024 | 631 | 0.170 |
Why?
|
| Geography | 2 | 2014 | 654 | 0.170 |
Why?
|
| Sex | 1 | 1999 | 53 | 0.170 |
Why?
|
| Physician's Role | 3 | 1996 | 926 | 0.170 |
Why?
|
| Legislation, Hospital | 1 | 2019 | 12 | 0.170 |
Why?
|
| Colorectal Neoplasms | 3 | 2008 | 6982 | 0.170 |
Why?
|
| Health Services Misuse | 1 | 2001 | 249 | 0.160 |
Why?
|
| Patient Compliance | 2 | 2007 | 2701 | 0.160 |
Why?
|
| Drug Industry | 2 | 2004 | 793 | 0.160 |
Why?
|
| Postal Service | 1 | 2019 | 96 | 0.160 |
Why?
|
| Kansas | 1 | 2018 | 37 | 0.160 |
Why?
|
| Accreditation | 1 | 2002 | 477 | 0.160 |
Why?
|
| Emergency Service, Hospital | 4 | 2024 | 7957 | 0.150 |
Why?
|
| Health Care Sector | 3 | 2013 | 197 | 0.150 |
Why?
|
| Indiana | 1 | 2018 | 93 | 0.150 |
Why?
|
| Information Systems | 3 | 2003 | 400 | 0.150 |
Why?
|
| Medical Audit | 3 | 2008 | 454 | 0.150 |
Why?
|
| Mental Disorders | 3 | 2014 | 6876 | 0.150 |
Why?
|
| Organizational Innovation | 1 | 2001 | 540 | 0.150 |
Why?
|
| Patient-Centered Care | 2 | 2008 | 1447 | 0.150 |
Why?
|
| Information Dissemination | 1 | 2006 | 1141 | 0.140 |
Why?
|
| Pulmonary Emphysema | 1 | 2003 | 689 | 0.140 |
Why?
|
| Prenatal Care | 3 | 1994 | 1162 | 0.140 |
Why?
|
| Odds Ratio | 11 | 2009 | 9684 | 0.140 |
Why?
|
| Ohio | 1 | 2018 | 321 | 0.140 |
Why?
|
| Adolescent | 29 | 2019 | 89244 | 0.140 |
Why?
|
| Medical Records | 5 | 2008 | 1411 | 0.140 |
Why?
|
| Survivors | 1 | 2007 | 2383 | 0.140 |
Why?
|
| Cohort Studies | 14 | 2023 | 41808 | 0.140 |
Why?
|
| Medicare Part C | 1 | 2002 | 332 | 0.140 |
Why?
|
| Professional Practice | 2 | 2017 | 314 | 0.130 |
Why?
|
| Workload | 1 | 2002 | 852 | 0.130 |
Why?
|
| Cross-Sectional Studies | 10 | 2021 | 26395 | 0.130 |
Why?
|
| Cardiology Service, Hospital | 1 | 1998 | 242 | 0.130 |
Why?
|
| Telephone | 2 | 2019 | 630 | 0.130 |
Why?
|
| Pneumonectomy | 1 | 2003 | 1159 | 0.130 |
Why?
|
| Coronary Angiography | 6 | 1997 | 4541 | 0.130 |
Why?
|
| Therapeutics | 1 | 1996 | 113 | 0.130 |
Why?
|
| Diagnostic Techniques and Procedures | 2 | 2010 | 219 | 0.130 |
Why?
|
| Boston | 13 | 1997 | 9377 | 0.130 |
Why?
|
| Comorbidity | 5 | 2020 | 10592 | 0.130 |
Why?
|
| Pandemics | 7 | 2024 | 8749 | 0.120 |
Why?
|
| Statistics, Nonparametric | 2 | 2018 | 2862 | 0.120 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2017 | 227 | 0.120 |
Why?
|
| Models, Economic | 2 | 2010 | 721 | 0.120 |
Why?
|
| Life Support Care | 2 | 1995 | 226 | 0.120 |
Why?
|
| Taxes | 1 | 2017 | 220 | 0.120 |
Why?
|
| Demography | 6 | 2008 | 1642 | 0.120 |
Why?
|
| Activities of Daily Living | 10 | 2022 | 2434 | 0.120 |
Why?
|
| Birth Certificates | 1 | 1994 | 71 | 0.120 |
Why?
|
| Indians, North American | 1 | 2018 | 354 | 0.120 |
Why?
|
| Cerebrovascular Disorders | 3 | 1998 | 1486 | 0.120 |
Why?
|
| Insurance, Hospitalization | 2 | 1991 | 30 | 0.120 |
Why?
|
| Sex Factors | 11 | 2018 | 10633 | 0.110 |
Why?
|
| Influenza Vaccines | 1 | 2001 | 781 | 0.110 |
Why?
|
| Insurance Claim Reporting | 1 | 1994 | 166 | 0.110 |
Why?
|
| Severity of Illness Index | 11 | 1999 | 15951 | 0.110 |
Why?
|
| Decision Making | 6 | 2012 | 3953 | 0.110 |
Why?
|
| Breast Neoplasms | 7 | 2011 | 21188 | 0.110 |
Why?
|
| District of Columbia | 1 | 2014 | 159 | 0.110 |
Why?
|
| Linear Models | 4 | 2011 | 5891 | 0.110 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2014 | 300 | 0.110 |
Why?
|
| Florida | 2 | 2012 | 430 | 0.110 |
Why?
|
| Pharmaceutical Preparations | 1 | 2002 | 1088 | 0.110 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2003 | 1741 | 0.110 |
Why?
|
| Infection Control | 1 | 2021 | 985 | 0.110 |
Why?
|
| Connecticut | 1 | 2014 | 365 | 0.110 |
Why?
|
| Medical Record Linkage | 1 | 1994 | 286 | 0.110 |
Why?
|
| Fee Schedules | 3 | 2004 | 87 | 0.100 |
Why?
|
| Health Status Indicators | 5 | 2000 | 971 | 0.100 |
Why?
|
| Maternal Welfare | 1 | 1993 | 113 | 0.100 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 1998 | 4056 | 0.100 |
Why?
|
| Health Care Coalitions | 2 | 2007 | 36 | 0.100 |
Why?
|
| Pennsylvania | 3 | 1999 | 615 | 0.100 |
Why?
|
| Hospitals, Proprietary | 2 | 2009 | 39 | 0.100 |
Why?
|
| Safety | 2 | 2011 | 1161 | 0.100 |
Why?
|
| Lower Extremity | 1 | 2020 | 1217 | 0.100 |
Why?
|
| Medical Oncology | 1 | 2004 | 2350 | 0.100 |
Why?
|
| Medical Assistance | 1 | 1993 | 108 | 0.100 |
Why?
|
| Health Surveys | 3 | 1992 | 4055 | 0.100 |
Why?
|
| Economic Competition | 3 | 2005 | 223 | 0.100 |
Why?
|
| Insurance, Physician Services | 1 | 1991 | 23 | 0.100 |
Why?
|
| Random Allocation | 4 | 2003 | 2394 | 0.100 |
Why?
|
| Forecasting | 3 | 2014 | 2945 | 0.100 |
Why?
|
| Geriatric Assessment | 4 | 1993 | 1422 | 0.090 |
Why?
|
| Advance Directives | 1 | 1993 | 249 | 0.090 |
Why?
|
| Supreme Court Decisions | 1 | 2013 | 135 | 0.090 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2004 | 3235 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2011 | 6236 | 0.090 |
Why?
|
| Cost Sharing | 2 | 2005 | 409 | 0.090 |
Why?
|
| Resuscitation | 1 | 1995 | 679 | 0.090 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2013 | 3683 | 0.090 |
Why?
|
| Censuses | 1 | 2011 | 198 | 0.090 |
Why?
|
| Self Disclosure | 1 | 2011 | 248 | 0.090 |
Why?
|
| Clinical Competence | 1 | 2006 | 4860 | 0.090 |
Why?
|
| Age Distribution | 1 | 2016 | 2875 | 0.090 |
Why?
|
| Utilization Review | 3 | 2001 | 384 | 0.090 |
Why?
|
| Disabled Persons | 2 | 2018 | 1210 | 0.090 |
Why?
|
| Hypertension | 8 | 2000 | 8617 | 0.080 |
Why?
|
| Adrenergic beta-Antagonists | 3 | 2007 | 1243 | 0.080 |
Why?
|
| Ownership | 2 | 2004 | 344 | 0.080 |
Why?
|
| Communication Barriers | 1 | 1993 | 419 | 0.080 |
Why?
|
| Risk Factors | 13 | 2017 | 74976 | 0.080 |
Why?
|
| Disease Management | 2 | 2016 | 2537 | 0.080 |
Why?
|
| Ticlopidine | 1 | 1994 | 730 | 0.080 |
Why?
|
| Private Practice | 3 | 1986 | 154 | 0.080 |
Why?
|
| Rhode Island | 4 | 1993 | 352 | 0.080 |
Why?
|
| Myocardial Revascularization | 1 | 1993 | 796 | 0.080 |
Why?
|
| Medically Underserved Area | 1 | 2011 | 267 | 0.080 |
Why?
|
| Exercise Test | 1 | 1997 | 2187 | 0.080 |
Why?
|
| Vaccination | 1 | 2001 | 3438 | 0.080 |
Why?
|
| Mandatory Programs | 1 | 2009 | 86 | 0.080 |
Why?
|
| Confidence Intervals | 2 | 2009 | 2932 | 0.080 |
Why?
|
| Dementia | 1 | 2023 | 2741 | 0.080 |
Why?
|
| Health Resources | 3 | 1990 | 951 | 0.080 |
Why?
|
| Anticholesteremic Agents | 1 | 1996 | 972 | 0.080 |
Why?
|
| AIDS-Related Complex | 1 | 1988 | 107 | 0.080 |
Why?
|
| Prospective Payment System | 2 | 1991 | 136 | 0.080 |
Why?
|
| Survival Analysis | 5 | 2007 | 10115 | 0.080 |
Why?
|
| Substance Abuse, Intravenous | 1 | 1993 | 530 | 0.080 |
Why?
|
| Models, Psychological | 1 | 1993 | 826 | 0.080 |
Why?
|
| Angiography | 2 | 1991 | 1598 | 0.080 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2019 | 1421 | 0.080 |
Why?
|
| Risk | 4 | 2017 | 9621 | 0.070 |
Why?
|
| Cholestyramine Resin | 1 | 1987 | 25 | 0.070 |
Why?
|
| Multivariate Analysis | 5 | 2009 | 12095 | 0.070 |
Why?
|
| Cholesterol | 3 | 1990 | 2913 | 0.070 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2019 | 1405 | 0.070 |
Why?
|
| Time Factors | 9 | 2017 | 40261 | 0.070 |
Why?
|
| Epidemiologic Methods | 1 | 1992 | 1328 | 0.070 |
Why?
|
| Education, Medical | 5 | 2007 | 1742 | 0.070 |
Why?
|
| Occult Blood | 1 | 2008 | 199 | 0.070 |
Why?
|
| Program Development | 1 | 2013 | 1300 | 0.070 |
Why?
|
| Treatment Outcome | 7 | 2012 | 65480 | 0.070 |
Why?
|
| Washington | 2 | 2005 | 315 | 0.070 |
Why?
|
| Statistics as Topic | 2 | 2011 | 2360 | 0.070 |
Why?
|
| Physician Executives | 1 | 2008 | 140 | 0.070 |
Why?
|
| Decision Making, Organizational | 1 | 2007 | 136 | 0.070 |
Why?
|
| Probability | 2 | 2009 | 2483 | 0.070 |
Why?
|
| Internship and Residency | 2 | 2002 | 5956 | 0.070 |
Why?
|
| Case-Control Studies | 3 | 2021 | 22296 | 0.070 |
Why?
|
| Cardiology | 2 | 2006 | 1701 | 0.070 |
Why?
|
| Internet | 1 | 2019 | 3112 | 0.070 |
Why?
|
| Contracts | 1 | 2006 | 60 | 0.070 |
Why?
|
| Evidence-Based Medicine | 4 | 2008 | 3709 | 0.070 |
Why?
|
| Psychotropic Drugs | 1 | 2012 | 881 | 0.070 |
Why?
|
| Health Priorities | 2 | 2006 | 380 | 0.060 |
Why?
|
| Prescription Fees | 2 | 2005 | 153 | 0.060 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2009 | 496 | 0.060 |
Why?
|
| Hospital Units | 1 | 1987 | 142 | 0.060 |
Why?
|
| Geriatrics | 2 | 1989 | 394 | 0.060 |
Why?
|
| Radiography, Thoracic | 4 | 1986 | 1321 | 0.060 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2006 | 169 | 0.060 |
Why?
|
| Nursing Staff, Hospital | 1 | 2009 | 350 | 0.060 |
Why?
|
| Hospitals, Public | 3 | 2011 | 204 | 0.060 |
Why?
|
| Likelihood Functions | 3 | 2011 | 994 | 0.060 |
Why?
|
| Oregon | 1 | 2005 | 149 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2003 | 7460 | 0.060 |
Why?
|
| Public Health Informatics | 1 | 2006 | 109 | 0.060 |
Why?
|
| Guidelines as Topic | 2 | 2002 | 1399 | 0.060 |
Why?
|
| Models, Organizational | 1 | 2008 | 549 | 0.060 |
Why?
|
| Hospitals, General | 1 | 2009 | 810 | 0.060 |
Why?
|
| Age Factors | 9 | 2018 | 18435 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2022 | 9264 | 0.060 |
Why?
|
| Angioplasty, Balloon | 1 | 1989 | 592 | 0.060 |
Why?
|
| Hospital Administrators | 1 | 2005 | 57 | 0.060 |
Why?
|
| Financial Management, Hospital | 1 | 1985 | 70 | 0.060 |
Why?
|
| Cesarean Section | 1 | 1993 | 1426 | 0.060 |
Why?
|
| Maryland | 3 | 1999 | 279 | 0.060 |
Why?
|
| Child | 11 | 2023 | 80960 | 0.060 |
Why?
|
| Chronic Disease | 4 | 2016 | 9384 | 0.060 |
Why?
|
| Survival Rate | 4 | 2004 | 12873 | 0.060 |
Why?
|
| Mandatory Reporting | 1 | 2005 | 123 | 0.060 |
Why?
|
| New Hampshire | 1 | 2004 | 174 | 0.060 |
Why?
|
| Career Mobility | 1 | 2006 | 262 | 0.060 |
Why?
|
| Acute Disease | 1 | 2014 | 7245 | 0.060 |
Why?
|
| Family Practice | 1 | 2006 | 509 | 0.050 |
Why?
|
| Medication Errors | 1 | 2009 | 785 | 0.050 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2012 | 3730 | 0.050 |
Why?
|
| Cross Infection | 2 | 2009 | 1425 | 0.050 |
Why?
|
| Financial Management | 1 | 1985 | 161 | 0.050 |
Why?
|
| Pneumococcal Vaccines | 1 | 2007 | 414 | 0.050 |
Why?
|
| Databases as Topic | 1 | 2005 | 475 | 0.050 |
Why?
|
| Patient Care | 1 | 2009 | 629 | 0.050 |
Why?
|
| Behavior | 1 | 1986 | 543 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2007 | 1514 | 0.050 |
Why?
|
| Personnel Staffing and Scheduling | 2 | 2002 | 497 | 0.050 |
Why?
|
| Medical Order Entry Systems | 1 | 2008 | 523 | 0.050 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2004 | 361 | 0.050 |
Why?
|
| Prejudice | 2 | 2001 | 574 | 0.050 |
Why?
|
| Continuity of Patient Care | 1 | 2010 | 1076 | 0.050 |
Why?
|
| Cancer Care Facilities | 1 | 2006 | 428 | 0.050 |
Why?
|
| Organizations | 2 | 2002 | 172 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3118 | 0.050 |
Why?
|
| Social Support | 2 | 2008 | 2193 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3241 | 0.050 |
Why?
|
| Qualitative Research | 1 | 2013 | 3143 | 0.050 |
Why?
|
| Contract Services | 1 | 2002 | 90 | 0.050 |
Why?
|
| Aspirin | 3 | 2007 | 3135 | 0.050 |
Why?
|
| Mental Health Services | 2 | 2011 | 1732 | 0.050 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2007 | 584 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 39394 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 8559 | 0.050 |
Why?
|
| Commerce | 1 | 2007 | 613 | 0.050 |
Why?
|
| Homes for the Aged | 1 | 2024 | 273 | 0.050 |
Why?
|
| Zidovudine | 2 | 1994 | 625 | 0.050 |
Why?
|
| Blood Glucose | 1 | 2016 | 6435 | 0.050 |
Why?
|
| Pregnancy Outcome | 1 | 1993 | 2974 | 0.050 |
Why?
|
| Computer Systems | 2 | 1996 | 470 | 0.050 |
Why?
|
| Organizational Affiliation | 1 | 2001 | 34 | 0.050 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2004 | 491 | 0.050 |
Why?
|
| Databases, Factual | 5 | 2021 | 8094 | 0.050 |
Why?
|
| United States Agency for Healthcare Research and Quality | 2 | 2000 | 86 | 0.050 |
Why?
|
| Clinical Laboratory Techniques | 2 | 1984 | 749 | 0.050 |
Why?
|
| Substance-Related Disorders | 3 | 2014 | 4423 | 0.050 |
Why?
|
| Education, Medical, Graduate | 2 | 1990 | 2422 | 0.050 |
Why?
|
| Financing, Personal | 1 | 2004 | 310 | 0.050 |
Why?
|
| Europe | 1 | 2008 | 3441 | 0.050 |
Why?
|
| Occupations | 3 | 1990 | 516 | 0.050 |
Why?
|
| Child, Preschool | 6 | 2012 | 42683 | 0.050 |
Why?
|
| Electrocardiography | 5 | 1986 | 6413 | 0.050 |
Why?
|
| Personality | 1 | 1984 | 560 | 0.050 |
Why?
|
| Predictive Value of Tests | 3 | 2009 | 15471 | 0.050 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2002 | 193 | 0.050 |
Why?
|
| Empirical Research | 1 | 2001 | 119 | 0.050 |
Why?
|
| Neoplasms | 3 | 2004 | 22389 | 0.040 |
Why?
|
| Radiotherapy | 1 | 2007 | 1506 | 0.040 |
Why?
|
| Diabetes Mellitus | 3 | 2016 | 5892 | 0.040 |
Why?
|
| Risk-Taking | 2 | 1997 | 1023 | 0.040 |
Why?
|
| Risk Assessment | 4 | 2022 | 24333 | 0.040 |
Why?
|
| Colonoscopy | 1 | 2008 | 1410 | 0.040 |
Why?
|
| England | 4 | 2013 | 533 | 0.040 |
Why?
|
| Organizational Policy | 1 | 2002 | 435 | 0.040 |
Why?
|
| Nephrology | 1 | 2004 | 270 | 0.040 |
Why?
|
| Confidentiality | 1 | 2004 | 606 | 0.040 |
Why?
|
| Drug Therapy | 1 | 2003 | 504 | 0.040 |
Why?
|
| Critical Care | 2 | 2008 | 2716 | 0.040 |
Why?
|
| Consumer Advocacy | 1 | 2000 | 83 | 0.040 |
Why?
|
| Incidence | 5 | 2009 | 21547 | 0.040 |
Why?
|
| Illinois | 1 | 1999 | 120 | 0.040 |
Why?
|
| Risk Sharing, Financial | 1 | 1999 | 47 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2011 | 3580 | 0.040 |
Why?
|
| Mastectomy | 1 | 2008 | 1850 | 0.040 |
Why?
|
| Algorithms | 2 | 2003 | 14201 | 0.040 |
Why?
|
| Medicine | 1 | 2007 | 947 | 0.040 |
Why?
|
| Life Expectancy | 3 | 1994 | 1249 | 0.040 |
Why?
|
| Primary Prevention | 1 | 1986 | 1187 | 0.040 |
Why?
|
| Hawaii | 1 | 2018 | 101 | 0.040 |
Why?
|
| Internationality | 1 | 2004 | 1008 | 0.040 |
Why?
|
| Hospitals, Community | 2 | 1991 | 365 | 0.040 |
Why?
|
| Infant, Newborn | 5 | 2004 | 26428 | 0.040 |
Why?
|
| Neoplasm Staging | 3 | 2010 | 11262 | 0.040 |
Why?
|
| Consumer Organizations | 1 | 1997 | 10 | 0.040 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 1 | 1998 | 91 | 0.040 |
Why?
|
| Feedback | 1 | 2002 | 799 | 0.040 |
Why?
|
| Planning Techniques | 1 | 1998 | 81 | 0.040 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2003 | 941 | 0.040 |
Why?
|
| Mammaplasty | 1 | 2008 | 1263 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 3 | 1995 | 1629 | 0.030 |
Why?
|
| Women's Health Services | 1 | 2017 | 88 | 0.030 |
Why?
|
| Resuscitation Orders | 1 | 1999 | 271 | 0.030 |
Why?
|
| Nursing Homes | 1 | 2024 | 1084 | 0.030 |
Why?
|
| Reproducibility of Results | 4 | 2011 | 20245 | 0.030 |
Why?
|
| Schizophrenia | 1 | 2015 | 6987 | 0.030 |
Why?
|
| Body Weight | 1 | 1987 | 4628 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2007 | 2145 | 0.030 |
Why?
|
| Certification | 1 | 1999 | 420 | 0.030 |
Why?
|
| Publications | 1 | 1998 | 195 | 0.030 |
Why?
|
| Postoperative Complications | 3 | 2009 | 15889 | 0.030 |
Why?
|
| Oxygen | 1 | 2007 | 4272 | 0.030 |
Why?
|
| Lipoprotein(a) | 1 | 2000 | 490 | 0.030 |
Why?
|
| Gemfibrozil | 1 | 1995 | 30 | 0.030 |
Why?
|
| Cerebral Infarction | 1 | 2000 | 975 | 0.030 |
Why?
|
| Longitudinal Studies | 4 | 2018 | 14794 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2007 | 2763 | 0.030 |
Why?
|
| Renal Dialysis | 2 | 2004 | 1789 | 0.030 |
Why?
|
| Affect | 2 | 1993 | 1500 | 0.030 |
Why?
|
| Asthma | 1 | 1994 | 6293 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2004 | 2276 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1984 | 1811 | 0.030 |
Why?
|
| Prescription Drugs | 1 | 2022 | 635 | 0.030 |
Why?
|
| Medical Indigency | 2 | 1993 | 63 | 0.030 |
Why?
|
| Blood Cell Count | 2 | 1986 | 406 | 0.030 |
Why?
|
| Delivery Rooms | 1 | 1994 | 38 | 0.030 |
Why?
|
| Prevalence | 3 | 2008 | 15879 | 0.030 |
Why?
|
| Government | 1 | 1995 | 161 | 0.030 |
Why?
|
| Infant | 5 | 2004 | 36556 | 0.030 |
Why?
|
| Drug Therapy, Combination | 2 | 2012 | 6320 | 0.030 |
Why?
|
| Urine | 2 | 1986 | 362 | 0.030 |
Why?
|
| Prostatectomy | 1 | 2002 | 1841 | 0.030 |
Why?
|
| Pregnancy | 5 | 2000 | 30265 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2002 | 1672 | 0.030 |
Why?
|
| Clinical Governance | 1 | 2013 | 7 | 0.030 |
Why?
|
| Academic Medical Centers | 2 | 1994 | 2784 | 0.030 |
Why?
|
| Prospective Studies | 5 | 2007 | 54962 | 0.030 |
Why?
|
| Drug Utilization Review | 2 | 2005 | 248 | 0.030 |
Why?
|
| Medicare Part A | 1 | 1993 | 40 | 0.030 |
Why?
|
| New Jersey | 1 | 1993 | 296 | 0.030 |
Why?
|
| Scotland | 1 | 2013 | 142 | 0.030 |
Why?
|
| Homosexuality | 1 | 1993 | 269 | 0.030 |
Why?
|
| Diabetic Retinopathy | 1 | 2002 | 1299 | 0.030 |
Why?
|
| Medical Informatics | 1 | 1999 | 742 | 0.030 |
Why?
|
| MEDLINE | 1 | 1992 | 119 | 0.020 |
Why?
|
| Blast Injuries | 1 | 1995 | 324 | 0.020 |
Why?
|
| Dental Care | 1 | 1994 | 286 | 0.020 |
Why?
|
| Financing, Government | 1 | 1995 | 473 | 0.020 |
Why?
|
| General Surgery | 2 | 2002 | 1722 | 0.020 |
Why?
|
| Tachycardia, Ventricular | 1 | 2000 | 1309 | 0.020 |
Why?
|
| Thyroid Function Tests | 1 | 1991 | 289 | 0.020 |
Why?
|
| Los Angeles | 1 | 2011 | 245 | 0.020 |
Why?
|
| Insurance Claim Review | 1 | 1995 | 746 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 1993 | 1002 | 0.020 |
Why?
|
| Public Health | 1 | 2023 | 2680 | 0.020 |
Why?
|
| Minnesota | 1 | 1990 | 339 | 0.020 |
Why?
|
| Anemia, Sickle Cell | 1 | 1998 | 1065 | 0.020 |
Why?
|
| Research Design | 3 | 2003 | 6214 | 0.020 |
Why?
|
| Heptanoic Acids | 1 | 1991 | 344 | 0.020 |
Why?
|
| Ethics, Medical | 1 | 1995 | 785 | 0.020 |
Why?
|
| Ancillary Services, Hospital | 1 | 1989 | 23 | 0.020 |
Why?
|
| Terminal Care | 3 | 1999 | 1772 | 0.020 |
Why?
|
| Choice Behavior | 1 | 1995 | 848 | 0.020 |
Why?
|
| Drugs, Generic | 2 | 2005 | 455 | 0.020 |
Why?
|
| Diet | 1 | 1987 | 8088 | 0.020 |
Why?
|
| Neutropenia | 1 | 1994 | 893 | 0.020 |
Why?
|
| Malpractice | 1 | 1993 | 561 | 0.020 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1988 | 113 | 0.020 |
Why?
|
| Ischemic Attack, Transient | 1 | 1994 | 877 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 7478 | 0.020 |
Why?
|
| Collagen Diseases | 1 | 1988 | 39 | 0.020 |
Why?
|
| Thyroid Diseases | 1 | 1991 | 385 | 0.020 |
Why?
|
| Rate Setting and Review | 1 | 1988 | 41 | 0.020 |
Why?
|
| Brain Ischemia | 2 | 1998 | 3008 | 0.020 |
Why?
|
| Receptors, LDL | 1 | 1990 | 492 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 1998 | 2339 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 1999 | 5323 | 0.020 |
Why?
|
| Registries | 2 | 1994 | 8384 | 0.020 |
Why?
|
| Environmental Exposure | 1 | 2022 | 4544 | 0.020 |
Why?
|
| ROC Curve | 1 | 1995 | 3629 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 1992 | 1364 | 0.020 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1994 | 1126 | 0.020 |
Why?
|
| Resource Allocation | 1 | 1989 | 354 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 2000 | 2780 | 0.020 |
Why?
|
| Causality | 1 | 1993 | 1256 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 1991 | 1026 | 0.020 |
Why?
|
| Hospitals, University | 1 | 1988 | 570 | 0.020 |
Why?
|
| Office Visits | 2 | 1988 | 596 | 0.020 |
Why?
|
| Informed Consent | 1 | 1992 | 1010 | 0.020 |
Why?
|
| International Agencies | 1 | 2006 | 244 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 1990 | 773 | 0.020 |
Why?
|
| Practice Management, Medical | 1 | 1987 | 192 | 0.020 |
Why?
|
| Social Behavior | 2 | 1989 | 1146 | 0.020 |
Why?
|
| Infectious Mononucleosis | 1 | 1986 | 133 | 0.020 |
Why?
|
| Capital Expenditures | 1 | 1985 | 27 | 0.020 |
Why?
|
| Education | 1 | 1988 | 533 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 1995 | 2403 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 1994 | 2055 | 0.020 |
Why?
|
| Models, Statistical | 2 | 1991 | 5110 | 0.010 |
Why?
|
| Hospitals, Special | 1 | 1985 | 90 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 13698 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 1990 | 15661 | 0.010 |
Why?
|
| Hospitals, Veterans | 1 | 1987 | 395 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 1990 | 1445 | 0.010 |
Why?
|
| Knee Prosthesis | 1 | 1987 | 395 | 0.010 |
Why?
|
| Death, Sudden | 1 | 1986 | 301 | 0.010 |
Why?
|
| Delphi Technique | 1 | 2008 | 890 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 1994 | 2008 | 0.010 |
Why?
|
| Recurrence | 3 | 2000 | 8513 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 14752 | 0.010 |
Why?
|
| Comprehension | 1 | 1989 | 639 | 0.010 |
Why?
|
| Sexual Behavior | 1 | 1993 | 2200 | 0.010 |
Why?
|
| Sickness Impact Profile | 1 | 2004 | 299 | 0.010 |
Why?
|
| Educational Status | 1 | 1990 | 2515 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 1997 | 12562 | 0.010 |
Why?
|
| Education, Continuing | 1 | 2003 | 115 | 0.010 |
Why?
|
| Angina Pectoris | 1 | 1986 | 957 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 1995 | 3070 | 0.010 |
Why?
|
| Blood Pressure Determination | 1 | 1986 | 646 | 0.010 |
Why?
|
| Organizational Case Studies | 1 | 2003 | 301 | 0.010 |
Why?
|
| Research | 1 | 1990 | 1981 | 0.010 |
Why?
|
| Insurance Benefits | 1 | 2003 | 187 | 0.010 |
Why?
|
| Self-Assessment | 1 | 1984 | 400 | 0.010 |
Why?
|
| Fellowships and Scholarships | 1 | 1990 | 1134 | 0.010 |
Why?
|
| Efficiency | 1 | 1985 | 480 | 0.010 |
Why?
|
| Health Behavior | 1 | 1993 | 2649 | 0.010 |
Why?
|
| Women's Health | 1 | 1991 | 2081 | 0.010 |
Why?
|
| Documentation | 1 | 2008 | 917 | 0.010 |
Why?
|
| Hip Prosthesis | 1 | 1987 | 924 | 0.010 |
Why?
|
| Prednisone | 1 | 1986 | 1567 | 0.010 |
Why?
|
| Methylphenidate | 1 | 2005 | 480 | 0.010 |
Why?
|
| Periodicals as Topic | 1 | 1992 | 1470 | 0.010 |
Why?
|
| Germany | 2 | 1993 | 883 | 0.010 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2006 | 1196 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 1990 | 2714 | 0.010 |
Why?
|
| Canada | 3 | 1993 | 2130 | 0.010 |
Why?
|
| Emotions | 2 | 1989 | 2768 | 0.010 |
Why?
|
| Prognosis | 2 | 2000 | 30046 | 0.010 |
Why?
|
| International Cooperation | 1 | 2006 | 1436 | 0.010 |
Why?
|
| Emergencies | 1 | 1986 | 1221 | 0.010 |
Why?
|
| Models, Econometric | 1 | 2000 | 215 | 0.010 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2003 | 390 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 1993 | 2974 | 0.010 |
Why?
|
| Therapeutic Irrigation | 1 | 2000 | 297 | 0.010 |
Why?
|
| Gynecology | 1 | 1985 | 534 | 0.010 |
Why?
|
| Mental Health | 1 | 1993 | 3275 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 1990 | 2403 | 0.010 |
Why?
|
| Proton Pump Inhibitors | 1 | 2003 | 552 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 2000 | 584 | 0.010 |
Why?
|
| Drug Approval | 1 | 2005 | 821 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2000 | 1266 | 0.010 |
Why?
|
| Cerebral Veins | 1 | 1998 | 159 | 0.010 |
Why?
|
| Consensus | 1 | 2006 | 3214 | 0.010 |
Why?
|
| Central Nervous System Stimulants | 1 | 2005 | 1170 | 0.010 |
Why?
|
| Cold Temperature | 1 | 2000 | 791 | 0.010 |
Why?
|
| Cerebral Arteries | 1 | 1998 | 489 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 2000 | 1056 | 0.010 |
Why?
|
| Mozambique | 1 | 1995 | 55 | 0.010 |
Why?
|
| Patient Care Team | 1 | 1987 | 2528 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1990 | 8055 | 0.010 |
Why?
|
| Cognition | 2 | 1989 | 7081 | 0.010 |
Why?
|
| Amputation, Traumatic | 1 | 1995 | 135 | 0.010 |
Why?
|
| Streptokinase | 1 | 1994 | 186 | 0.010 |
Why?
|
| Focus Groups | 1 | 2000 | 1462 | 0.010 |
Why?
|
| Radiography | 1 | 1984 | 6991 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2000 | 1320 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2006 | 8748 | 0.010 |
Why?
|
| Cerebral Angiography | 1 | 1998 | 1272 | 0.010 |
Why?
|
| Sick Role | 1 | 1993 | 229 | 0.010 |
Why?
|
| Health Services Administration | 1 | 1993 | 63 | 0.010 |
Why?
|
| Echocardiography | 1 | 1985 | 5047 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 1994 | 691 | 0.010 |
Why?
|
| Communication | 1 | 1985 | 3908 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 417 | 0.010 |
Why?
|
| Urban Population | 1 | 1998 | 2046 | 0.010 |
Why?
|
| Job Satisfaction | 1 | 1993 | 548 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1985 | 8544 | 0.000 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2003 | 3253 | 0.000 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1994 | 1165 | 0.000 |
Why?
|
| Cerebrovascular Circulation | 1 | 1998 | 2734 | 0.000 |
Why?
|
| Waiting Lists | 1 | 1993 | 779 | 0.000 |
Why?
|
| Stroke Volume | 1 | 2000 | 5622 | 0.000 |
Why?
|
| Obesity | 1 | 1987 | 13091 | 0.000 |
Why?
|
| Rabbits | 1 | 1990 | 4774 | 0.000 |
Why?
|
| Heart Defects, Congenital | 1 | 2000 | 4712 | 0.000 |
Why?
|
| Smoking | 1 | 2000 | 9094 | 0.000 |
Why?
|
| Transfection | 1 | 1990 | 5763 | 0.000 |
Why?
|
| Fetal Death | 1 | 1984 | 434 | 0.000 |
Why?
|
| Reoperation | 1 | 1992 | 4342 | 0.000 |
Why?
|
| Leukocyte Count | 1 | 1986 | 1609 | 0.000 |
Why?
|
| Psychometrics | 1 | 1991 | 3066 | 0.000 |
Why?
|
| Antigens, Viral | 1 | 1986 | 996 | 0.000 |
Why?
|
| Wales | 1 | 1981 | 87 | 0.000 |
Why?
|
| Herpesvirus 4, Human | 1 | 1986 | 1082 | 0.000 |
Why?
|
| Base Sequence | 1 | 1990 | 12430 | 0.000 |
Why?
|
| Infant Mortality | 1 | 1984 | 754 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1990 | 17629 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1986 | 2614 | 0.000 |
Why?
|
| Curriculum | 1 | 1990 | 3782 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1990 | 19023 | 0.000 |
Why?
|
| Liver | 1 | 1990 | 7578 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1991 | 10400 | 0.000 |
Why?
|
| Antibodies, Viral | 1 | 1986 | 3215 | 0.000 |
Why?
|
| Animals | 1 | 1990 | 169335 | 0.000 |
Why?
|